Gandara, D. R., Mack, P. C., Omori, A., Grimminger, P., Lara, P. N., Joshi, M.-B., … Danenberg, K. D. (2009). Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy. In JOURNAL OF THORACIC ONCOLOGY (Vol. 4, pp. S400–S400). LIPPINCOTT WILLIAMS & WILKINS.

Gandara, David R., Philip C. Mack, Akiko Omori, Peter Grimminger, Primo N. Lara, Mary-Beth M. Joshi, David H. Harpole, and Kathleen D. Danenberg. “Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy.” In JOURNAL OF THORACIC ONCOLOGY, 4:S400–S400. LIPPINCOTT WILLIAMS & WILKINS, 2009.

Gandara DR, Mack PC, Omori A, Grimminger P, Lara PN, Joshi M-BM, et al. Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy. In: JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S400–S400.

Gandara, David R., et al. “Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy.” JOURNAL OF THORACIC ONCOLOGY, vol. 4, no. 9, LIPPINCOTT WILLIAMS & WILKINS, 2009, pp. S400–S400.

Gandara DR, Mack PC, Omori A, Grimminger P, Lara PN, Joshi M-BM, Harpole DH, Danenberg KD. Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S400–S400.